CERUS CORP

CERS ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $76.1M $51.3M $39.3M $34.2M $36.4M $39.7M $36.8M $33.0M
Cost of Revenue $31.6M $22.5M $20.3M $23.5M $21.2M $22.6M $20.6M $18.5M
Gross Profit $44.4M $28.8M $16.9M $10.8M $15.2M $17.1M $16.1M $12.1M
Gross Margin 58.4% 56.1% 43.0% 31.4% 41.8% 43.0% 43.7% 36.5%
Operating Expenses
Research & Development
SG&A Expense $56.8M $52.6M $49.0M $46.0M $37.7M $30.0M $25.7M $23.1M
Operating Income $-55.0M $-57.5M $-61.4M $-61.1M $-44.5M $-28.3M $-17.3M $-15.9M
Operating Margin -72.3% -112.1% -156.5% -178.5% -122.2% -71.4% -47.0% -48.2%
Interest Expense $4.0M $3.0M $2.4M $1.7M $599.0K $332.0K $551.0K $964.0K
Pretax Income $-57.3M $-56.7M $-62.7M $-59.5M $-38.6M $-43.1M $-15.7M $-16.8M
Income Tax Expense $229.0K $3.9M $175.0K $-3.7M $195.0K $218.0K $242.0K $143.0K
Net Income $-57.6M $-60.6M $-62.9M $-55.9M $-38.8M $-43.3M $-15.9M $-17.0M
Net Margin -75.7% -118.0% -160.2% -163.2% -106.4% -109.3% -43.3% -51.4%
EPS (Basic) $-0.44 $-0.56 $-0.62 $-0.58 $-0.52 $-0.64 $-0.29 $-0.35
EPS (Diluted) $-0.44 $-0.56 $-0.62 $-0.61 $-0.61 $-0.64 $-0.33 $-0.35
Shares Outstanding (Basic) 131.7M 108.2M 101.8M 96.1M 74.8M 67.6M 54.5M 48.1M
Shares Outstanding (Diluted) 131.7M 108.2M 101.8M 96.9M 76.5M 67.6M 55.1M 48.1M
Dividends Per Share
← Newer Page 2 of 3 Older →